Go to main page
  • To main page
  • Download report
  • Privacy
  • Legal
  • Language (DA)
  • Novozymes.com
  • Profile
  • Activities
  • Accounts, Data and Other information
 
  • Recombinant ingredients
  • Innovation
  • Microorganisms and genetic engineering
  • Bioethanol
  • Global warming
  • Asia - a growth area
  • Facilitating

Recombinant ingredients

Ingredients produced with the help of gene technology, so-called recombinant ingredients, are gaining ground in the biopharmaceutical industry. Novozymes came a big step closer to its goal of being a leading supplier of recombinant ingredients in 2006 with the acquisitions of UK company Delta and Australian company GroPep.

Innovation

Novozymes’ innovation is wide-ranging, and we are pursuing a strategy of moving into new areas where we can apply our core technologies. In the enzyme business, we have set ourselves the target of promoting innovation and finding completely new and different ways of using enzymes.

Bioethanol

Cars that run on second-generation bioethanol are a realistic possibility within the foreseeable future. Novozymes is conducting intensive research into this very technology and entered into new collaboration agreements in both the USA and China in 2006. But the potential for substituting crude oil with biomass goes beyond just bioethanol.